Skip to main content

Intelligent Bio Solutions Inc.

INBS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001725430

No open-market purchases or sales by Intelligent Bio Solutions Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $416.2K in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Intelligent Bio Solutions Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of INBS: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders127−5
Shares1.35M5.66K−1.35M (−99.6%)
Value$1.38M$53.0K−$1.33M (−96.2%)

New holders (3)

Institutions that held Intelligent Bio Solutions Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to INBS in Q4 2025
InstitutionSharesValue% of portfolio
UBS Group AG4,054$38.6K0.00%
Tower Research Capital LLC (TRC)1,260$12.0K0.00%
SHP Wealth Management25$2380.00%

Sold out (8)

Institutions that held Intelligent Bio Solutions Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of INBS in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Alyeska Investment Group, L.P.673,492$687.0K
ADAR1 Capital Management, LLC426,433$435.0K
Vanguard Group Inc97,686$99.6K
Geode Capital Management, LLC58,873$60.0K
Warberg Asset Management LLC44,693$45.6K
LPL Financial LLC25,000$25.5K
Goldman Sachs Group Inc12,830$13.1K
NBC Securities, Inc.2,641$2.69K